Randomized, Double-blind, Placebo-controlled, Multicenter, Multi-arm, Phase II Trial of Novel Agents for the Treatment of Mild to Moderate COVID-19 Positive Outpatients

Palazuelos et al., NCT04530617, NCT04530617, Jun 2021
246 patient camostat early treatment RCT with results not reported over 5 years after completion.
5 camostat RCTs have results missing long after expected1-5
The trials report a total of 828 patients, with 4 trials having actual enrollment of 578, and the other estimated.
Palazuelos et al., 10 Jun 2021, Double Blind Randomized Controlled Trial, placebo-controlled, Mexico, trial NCT04530617 (history).